Letter to the Editor: Is Aspirin a Drug or Just a Marker for Biliary Cancer?

Hepatology. 2021 Nov;74(5):2924. doi: 10.1002/hep.32052. Epub 2021 Aug 26.

Authors

Jun-Wei Zhang¹, Xu Yang¹, Hui-Ru Ding², Lei Zhang¹, Yi-Yao Xu¹, Xin-Ting Sang¹, Hai-Tao Zhao¹, Wei-Guang Zhang², Xin Lu¹

Affiliations

¹ Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
² Department of Human Anatomy, Histology & Embryology, School of Basic Medical Sciences, Peking University, Beijing, China.

PMID: 34242426
DOI: 10.1002/hep.32052

No abstract available

Publication types

Letter
Comment

MeSH terms

Arthroplasty, Replacement, Knee*
Aspirin / adverse effects
Biliary Tract Neoplasms* / drug therapy
Biomarkers
Humans
Pharmaceutical Preparations*

Substances

Biomarkers
Pharmaceutical Preparations
Aspirin